COMPLEGENT Trademark

Trademark Overview


On Wednesday, June 30, 2021, a trademark application was filed for COMPLEGENT with the United States Patent and Trademark Office. The USPTO has given the COMPLEGENT trademark a serial number of 90803650. The federal status of this trademark filing is REGISTERED as of Tuesday, December 6, 2022. This trademark is owned by Kyowa Kirin Co., Ltd.. The COMPLEGENT trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Contract manufacturing service in the field of antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of host cells; custom manufacturing, namely, contract refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals; providing information in the field of custom manufacturing in the field of antibodies, fragments of antibodies, and derivatives of antibodies; technical consultation in the field of custom manufacturing in the field of antibodies, fragments of antibodies, and derivatives of antibodies; providing information in the field of custom manufacturing in the field of cells that manufacture antibo...

Development of new products for others in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, and host cells; Providing technical information in the field of development of new products in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, and host cells; Technical consultation in the field of development of new products in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibod...
complegent

General Information


Serial Number90803650
Word MarkCOMPLEGENT
Filing DateWednesday, June 30, 2021
Status700 - REGISTERED
Status DateTuesday, December 6, 2022
Registration Number6915728
Registration DateTuesday, December 6, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 20, 2022

Trademark Statements


Goods and ServicesContract manufacturing service in the field of antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of host cells; custom manufacturing, namely, contract refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals; providing information in the field of custom manufacturing in the field of antibodies, fragments of antibodies, and derivatives of antibodies; technical consultation in the field of custom manufacturing in the field of antibodies, fragments of antibodies, and derivatives of antibodies; providing information in the field of custom manufacturing in the field of cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; technical consultation in the field of custom manufacturing in the field of cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; providing information in the field of custom manufacturing in the field of transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; technical consultation in the field of custom manufacturing in the field of transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; providing information in the field of custom manufacturing in the field of host cells; technical consultation in the field of custom manufacturing in the field of host cells; providing technical information in the field of contract manufacturing that consists of extracting, refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals; technical consultation in the field of manufacturing that consists of extracting, refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals
Certificate of Correction for RegistrationIn the statement, " 11/28/2018 and 11/20/2028 " should be deleted, and 11/28/2008 and 11/28/2028 should be inserted. In the statement, 06/12/2018 is inserted.
Goods and ServicesDevelopment of new products for others in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, and host cells; Providing technical information in the field of development of new products in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, and host cells; Technical consultation in the field of development of new products in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, and host cells

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateSunday, September 12, 2021
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, September 12, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKyowa Kirin Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTokyo 100-0004
JP

Party NameKyowa Kirin Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 100-0004
JP

Party NameKyowa Kirin Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 100-0004
JP

Trademark Events


Event DateEvent Description
Tuesday, August 8, 2023NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Thursday, July 6, 2023CORRECTION UNDER SECTION 7 ¿ PROCESSED
Monday, July 3, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, December 21, 2022TEAS SECTION 7 REQUEST RECEIVED
Tuesday, December 6, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 6, 2022REGISTERED-PRINCIPAL REGISTER
Monday, November 14, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, October 20, 2022ASSIGNED TO PETITION STAFF
Wednesday, October 5, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, September 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 20, 2022PUBLISHED FOR OPPOSITION
Wednesday, August 31, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, August 13, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 27, 2022PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Wednesday, July 27, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, July 26, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 25, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 25, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 16, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 16, 2022NON-FINAL ACTION E-MAILED
Wednesday, February 16, 2022NON-FINAL ACTION WRITTEN
Wednesday, February 9, 2022ASSIGNED TO EXAMINER
Wednesday, July 21, 2021TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Wednesday, July 21, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Sunday, September 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 3, 2021NEW APPLICATION ENTERED